Browsing by Subject "Nystatine"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Restricted
    Use of antifungal agents for oral candidiasis: results of a national survey
    (Wiley, 2010-02-01) Martínez Beneyto, Yolanda; López-Jornet, Pia; Velandrino-Nicolás, A.; Jornet García, V.; Dermatología, Estomatología, Radiología y Medicina Física
    Abstract: Background: Candida albicans is an opportunistic agent that colonizes the oral mucosa. Objectives: To determine the attitude of Spanish dentists toward the oral treatment of candidiasis. Method: Between May and November 2006, a questionnaire was circulated to a random selection of 1134 dentists obtained from the General Dental Council’s main list. The survey consisted of a block of socio-demographic items followed by another block related to the diagnosis and treatment of oral candidiasis. Replies to the questionnaire were received from 840 (74%) dentists. Results: 50.4% of respondents were men, and 48.1% were female with a mean age of 38 and 12.2 years of professional experience. Miconazole was the most popular choice of antifungal agent prescribed (59.3%), followed by nystatin (57.7%) for topical use. Systemic antifungal agents were used by 30.20% of dentists, with a strong association between their use and the number of years in practice, gender and professional qualifications (P < 0.005). Conclusion: Most Spanish dentists make clinical diagnosis and treat oral infections by C. albicans themselves with topical drugs (miconazole and nystatin) as a first choice. Systemic treatments are more commonly chosen by male dentists with long professional experience, especially by stomatologists.